ArticleScientific reports2025
A novel deep neural architecture for efficient and scalable multidomain image classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning has significantly advanced the field of computer vision; however, developing models that generalize effectively across diverse image domains remains a major research challenge. In this study, we introduce DeepFreqNet, a novel deep neural architecture specifically designed for high-performance multi-domain image classification. The innovative aspect of DeepFreqNet lies in its combination of three powerful components: multi-scale feature extraction for capturing patterns at different resolutions, depthwise separable convolutions for enhanced computational efficiency, and residual connections to maintain gradient flow and accelerate convergence. This hybrid design improves the architecture's ability to learn discriminative features and ensures scalability across domains with varying data complexities. Unlike traditional transfer learning models, DeepFreqNet adapts seamlessly to diverse datasets without requiring extensive reconfiguration. Experimental results from nine benchmark datasets, including MRI tumor classification, blood cell classification, and sign language recognition, demonstrate superior performance, achieving classification accuracies between 98.96% and 99.97%. These results highlight the effectiveness and versatility of DeepFreqNet, showcasing a significant improvement over existing state-of-the-art methods and establishing it as a robust solution for real-world image classification challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.